Related Experiment Video
Updated: Aug 2, 2025

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
A review of penicillin binding protein and group A Streptococcus with reduced-β-lactam susceptibility
Dingle Yu1, Danchun Guo1, Yuejie Zheng1
1Shenzhen Children's Hospital, Shenzhen, China.
Abstract:
With the widespread use of antibiotics, antimicrobial resistance (AMR) has become a global problem that endangers public health. Despite the global high prevalence of group A Streptococcus (GAS) infections and the global widespread use of β-lactams, β-lactams remain the first-line treatment option for GAS infection. β-hemolytic streptococci maintain a persistent susceptibility to β-lactams, which is an extremely special phenomenon in the genus Streptococci, while the exact current mechanism is not known. In recent years, several studies have found that the gene encoding penicillin binding protein 2X (pbp2x) is associated with GAS with reduced-β-lactam susceptibility. The purpose of this review is to summarize the current published data on GAS penicillin binding proteins and β-lactam susceptibility, to explore the relationship between them, and to be alert to the emergence of GAS with reduced susceptibility to β-lactams.
Insights
Antimicrobial resistance is a global health threat. This review examines penicillin-binding proteins in Group A Streptococcus (GAS) and their unusual susceptibility to beta-lactam antibiotics, highlighting potential resistance mechanisms.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antimicrobial resistance (AMR) poses a significant global public health risk.
- Group A Streptococcus (GAS) infections are prevalent worldwide, with beta-lactam antibiotics remaining the primary treatment.
- A unique characteristic of beta-hemolytic streptococci is their sustained susceptibility to beta-lactams, a mechanism not fully understood.
Purpose of the Study:
- To review current literature on GAS penicillin-binding proteins (PBPs) and their link to beta-lactam susceptibility.
- To investigate the relationship between specific PBPs and beta-lactam resistance in GAS.
- To raise awareness regarding the potential emergence of GAS strains with reduced susceptibility to beta-lactams.
Main Methods:
- Literature review of published studies.
- Analysis of data concerning GAS penicillin-binding proteins.
- Examination of findings related to beta-lactam susceptibility in GAS.
Main Results:
- Recent research implicates the penicillin-binding protein 2X (pbp2x) gene in reduced beta-lactam susceptibility in GAS.
- The exact mechanisms driving beta-hemolytic streptococci's persistent susceptibility to beta-lactams require further elucidation.
Conclusions:
- Understanding the role of PBPs, particularly pbp2x, is crucial for monitoring GAS beta-lactam susceptibility.
- Continued vigilance is necessary to detect and address the potential rise of beta-lactam-resistant GAS strains.
More Related Videos
08:53Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Related Concept Videos
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Development of Antibiotic Resistance
Bacterial Cell Wall
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Combined Effects of Drugs: Synergism
Such synergistic combinations...